M Ohtani - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

M Ohtani

Showing results (241-250 of 242) with videos related to

Pageof 25

Sort By:

You have reached the last page of results.This site can display upto 242 results.

Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 1, 1997

[Evaluation of urinary NMP22 (nuclear matrix protein 22) as a diagnostic marker for urothelial cancer--screening for urothelial cancer in patients with microscopic hematuria. NMP Study Group]H Akaza, N Miyanaga, T Tsukamoto, et al.

Cancer Research|March 30, 1999

Correlation of antiangiogenic and antitumor efficacy of N-biphenyl sulfonyl-phenylalanine hydroxiamic acid (BPHA), an orally-active, selective matrix metalloproteinase inhibitorR Maekawa, H Maki, H Yoshida, et al.

Pageof 25

Search research articles

Showing results (241-250 of 242) with videos related to

Sort By:

Pageof 25

You have reached the last page of results.This site can display upto 242 results.

Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 1, 1997

[Evaluation of urinary NMP22 (nuclear matrix protein 22) as a diagnostic marker for urothelial cancer--screening for urothelial cancer in patients with microscopic hematuria. NMP Study Group]H Akaza, N Miyanaga, T Tsukamoto, et al.

Cancer Research|March 30, 1999

Correlation of antiangiogenic and antitumor efficacy of N-biphenyl sulfonyl-phenylalanine hydroxiamic acid (BPHA), an orally-active, selective matrix metalloproteinase inhibitorR Maekawa, H Maki, H Yoshida, et al.

Pageof 25